Ad is loading...
JVTCX vs VEXPX
JVTCX vs VEXPX Comparison
Open Charts JVTCX vs VEXPX
Janus Henderson Venture C
Price$71.12
Change-$0.71 (-0.99%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VS
VS
JVTCX vs VEXPX Comparison Chart
Loading...
JVTCX vs. VEXPX commentary
Sep 21, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVTCX is a Buy and VEXPX is a Buy.
FUNDAMENTALS
Fundamentals
VEXPX has more cash in the bank: 22.6B vs. JVTCX (3.25B). VEXPX pays higher dividends than JVTCX: VEXPX (0.48) vs JVTCX (0.00). JVTCX was incepted earlier than VEXPX: JVTCX (13 years) vs VEXPX (57 years). VEXPX is a more actively managed with annual turnover of: 40.00 vs. JVTCX (23.00). JVTCX has a lower initial minimum investment than VEXPX: JVTCX (2500) vs VEXPX (3000). VEXPX annual gain was more profitable for investors over the last year : 22.97 vs. JVTCX (14.19). VEXPX return over 5 years is better than : 21.05 vs. JVTCX (-2.35).
| JVTCX | VEXPX | JVTCX / VEXPX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 13 years | 57 years | - |
| Gain YTD | 11.349 | 11.283 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.25B | 22.6B | 14% |
| Annual Yield % from dividends | 0.00 | 0.48 | - |
| Returns for 1 year | 14.19 | 22.97 | 62% |
| Returns for 3 years | -27.45 | -15.01 | 183% |
| Returns for 5 years | -2.35 | 21.05 | -11% |
| Returns for 10 years | 10.67 | 20.45 | 52% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TQSAX | 23.72 | 0.04 | +0.17% |
| T. Rowe Price Integrated US SMCC Eq Adv | |||
| DSCIX | 14.84 | 0.02 | +0.13% |
| Dana Epiphany Small Cap Eq Instl | |||
| FBTTX | 30.80 | 0.02 | +0.06% |
| Fidelity Advisor Biotechnology M | |||
| AMDVX | 17.03 | N/A | N/A |
| American Century Mid Cap Value R6 | |||
| NWHLX | 9.91 | -0.03 | -0.30% |
| Nationwide Bailard Intl Eqs M | |||